All In Biotech

Free tool

FAERS Monitor: Miostat

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 016968 or its brand name (Miostat, Carbachol). Reports on generic versions are filed under their own applications.

Reports

167

Serious

132

79% of reports

Hospitalization

54

Death reported

3

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use35
  • abdominal discomfort33
  • drug abuse32
  • lower respiratory tract infection32
  • product dose omission issue32
  • amyloid arthropathy31
  • arthropathy31
  • intentional product misuse31
  • obesity31
  • pulmonary pain31
  • rash31
  • drug dependence30
  • overdose30
  • knee arthroplasty28
  • endophthalmitis24

Reports by year received

View as table
YearReports
20042
20056
200614
200710
20081
20098
201013
20114
201210
20133
20146
20158
20169
201711
20186
20193
20203
202115
202211
20231
20248
20254
202611

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,992 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
amyloid arthropathySignal31100210.964117.11,675,375
pulmonary painSignal311351.9981.940,082
endophthalmitisSignal24505.9349.111,551
obesitySignal31245.6178.77,300
knee arthroplastySignal28167.7119.64,474
lower respiratory tract infectionSignal3288.764.92,691
arthropathySignal3170.351.12,053
drug abuseSignal3248.435.51,445
intentional product misuseSignal3144.632.51,283
abdominal discomfortSignal3324.818.3735
drug dependenceSignal3023.517.0629
overdoseSignal3017.512.7455
product dose omission issueSignal3213.710.0369
rashSignal319.06.5216
off label useSignal355.03.7114

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.